We’re excited to share that Ipatimup, a leading pathology lab in Portugal, has published a new study in Virchow’s Archiv, evaluating the clinical utility of Paige PanCancer, an AI-assisted diagnostic application designed to detect cancer across multiple tissue types. The study assessed 62 challenging cases spanning 16 tissue types, demonstrating a sensitivity of over 93% and a specificity of 87.5%. These findings highlight the potential of Paige PanCancer to streamline diagnostic workflows and support pathologists in addressing even the most complex cases. A special thanks to the dedicated Ipatimup team; Catarina Eloy, Iván Rienda-Martínez, João Vale, João Correia Pinto, António Polónia, who are advancing digital pathology and contributing to better cancer diagnostics worldwide. Read the full study, Using artificial intelligence to prioritize pathology samples: report of a test drive: https://lnkd.in/etatdHjV
Paige
Software Development
New York City, New York 15,247 followers
Bridging Vision & Precision
About us
Paige is using the power of AI to drive a new era of cancer discovery and treatment. To improve the lives of patients with cancer, Paige has created a cloud-based platform that transforms pathologists’ workflow and increases diagnostic confidence as well as productivity, all on a global scale. Paige is the first company to receive FDA approval for a clinical AI application in digital pathology. The same Paige technology empowers pharmaceutical companies to more effectively evaluate treatment options for patients and design new biomarkers for drug development so that every patient gets precise treatment options. Learn more about Paige: https://www.paige.ai
- Website
-
http://paige.ai
External link for Paige
- Industry
- Software Development
- Company size
- 51-200 employees
- Headquarters
- New York City, New York
- Type
- Privately Held
- Founded
- 2018
- Specialties
- Pathology, artificial intelligence, machine learning, cancer, computational pathology, Digital Pathology, Diagnostic Support, Healthcare, Cancer Detection, Clinical-Grade AI, Diagnostic AI, Biomarker AI Applications, Clinical Trial Enrichment, and Algorithm Development & Deployment
Locations
-
Primary
11 Times Square
New York City, New York 10036, US
Employees at Paige
Updates
-
Heading to DP&AI London this week? Visit us at booth #5 to explore how our AI-powered diagnostic applications seamlessly integrate into partner platforms. Plus, experience Paige Alba, our clinical pathology co-pilot, in action! See you there! #DigipathLondon
-
Virchow2 has been ranked #1 on the Eva leaderboard, a leading evaluation framework for oncology foundation models by kaiko.ai. Eva rigorously assessed 13 foundation models on 6 WSI-classification tasks using a fixed protocol that prioritizes fairness and comparability over state-of-the-art performance. Virchow2 achieved state-of-the-art performance across classification and segmentation tasks for various tissue types, including breast, colorectal, kidney, lung, and prostate. What sets Virchow2 apart? ☑️ Trained on 3M whole slide images of H&E and IHC samples ☑️ Learning across 5x, 10x, 20x, and 40x magnifications ☑️ Available as a commercial or an open-weights model via Hugging Face and Azure AI Studio Explore Virchow2 and learn why it’s setting a new standard in the field: 📈 Leaderboard: https://lnkd.in/ghUY6zyR 💻 Hugging Face: https://lnkd.in/gTG_j3bw ☁️ Azure AI Foundry: aka.ms/Virchow2
-
We're thrilled to be at Radiological Society of North America (RSNA) 2024 Annual Meeting in Chicago this week! We're pushing the boundaries of innovation in cancer diagnostics, and we’re excited to demonstrate our clinical co-pilot, Alba, in the Microsoft booth. Here we are showcasing how Paige’s multi-modal AI technology could transform future cancer diagnostic workflows by seamlessly integrating radiology and pathology findings and unlocking new possibilities for a comprehensive understanding of the patient, enabling more informed clinical decisions. If you're at RSNA, don’t miss the chance to see Alba in action and learn how Paige is revolutionizing cancer diagnostics. Stop by the Microsoft booth to experience the future of integrated diagnostics. Let’s reimagine what’s possible in cancer care, together!
-
We are excited to announce our new partnership with PathAI! Our AI suites—Paige Prostate, Paige Breast, Paige Colon, and Paige Pan-Cancer—are now available on AISight, PathAI’s image management system. This milestone marks our 5th platform integration, underscoring our commitment to advancing digital pathology. By working together, Paige and PathAI are ensuring pathologists have access to the most comprehensive and cutting-edge solutions in the field. https://lnkd.in/eTqX-tKw
We're excited to announce partnerships and integrations with several leading #AI digital pathology companies - Deep Bio Inc., DoMore Diagnostics, Paige, and Visiopharm - through our AISight® Image Management System! 🔗 Read the #PressRelease: https://lnkd.in/eTqX-tKw These partnerships will enable seamless access for pathologists to top-tier AI algorithms, boosting #pathology workflow efficiency, #biomarker quantification, risk stratification, and more. PathAI is committed to offering the most versatile, reliable, and interoperable IMS on the market. This is a major step forward in bringing cutting-edge technologies to the fingertips of #pathologists, to enhance #diagnostics and improve patient outcomes. Learn more or contact us at digitaldx@pathai.com. #DigitalPathology #Innovation #Partnerships #AISight #biotech #biotechnology #AIinHealthcare #healthtech -AISight® is for Research Use Only in the US; AISight Dx is CE-IVD in Europe and UKCA in UK
-
Introducing Virchow2G Mini: High-Performance Pathology AI Optimized for Speed We’re excited to announce Virchow2G Mini, the latest addition to Paige’s Virchow model suite, developed in collaboration with Microsoft Research. Designed for high-throughput workflows, Virchow2G Mini delivers pathology insights, with remarkable performance at a fraction of the computational cost. As a research tool, Virchow2G Mini is designed for large scale screening and rapid development iterations. Key Features: -Optimized for inference speed with minimal compromise on accuracy -Supports pan-tissue pathology across 5X to 40X magnifications -Handles IHC and H&E stains, all within a compact 21M-parameter model Virchow2G Mini delivers comparable performance to our original Virchow model, recently described in Nature Medicine, with the capabilities of Virchow2G at only 1% of the inference cost, making it a breakthrough for scalable pathology AI. For further technical details, read our latest report: https://lnkd.in/dbpzP325
-
We’re excited to further expand the reach of Paige’s diagnostic AI applications through a new partnership with Aiforia Technologies! This collaboration integrates our advanced diagnostic solutions directly into the Aiforia platform, making our AI technology more accessible to pathologists in both clinical and research settings. Together, we’re enhancing the tools available to support diagnostic excellence and drive innovation in digital pathology.
Aiforia and Paige form strategic partnership to advance AI in pathology! This partnership brings Paige's AI applications to the AiforiaⓇ Platform, giving users even broader access to cutting-edge tools for enhanced lab efficiency and diagnostic confidence. Read more: https://hubs.la/Q02WM5xF0
-
Day 1 of Pathology Visions is officially in the books! We kicked off with an insightful joint seminar with PathPresenter where we discussed the vital role of vendor interoperability in digital pathology. Together, we showcased how Paige is seamlessly integrating with the PathPresenter platform, bringing cutting-edge AI to even more pathologists. Later, we took the stage to reveal the future of integrated workflows, spotlighting Alba—our clinical-grade co-pilot for pathology. Alba’s capabilities represent a new era of support for pathologists, enabling them to work more effectively with AI-driven insights. We wrapped up the day with a lively networking reception, where we provided a hands-on demonstration of Alba and our suite of diagnostic AI applications. Can’t wait to see what Day 2 has in store! Stop by and see us at Booth #113
-
We’re headed to #PathologyVisions! Join us tomorrow at 2:45 PM for our pre-conference workshop, "Are AI Co-Pilots the Future of Pathology? Discover the Potential with Paige Alba™." We'll be diving into the transformative potential of AI in pathology and showcasing how Paige Alba™ could transform the day to day of pathologists. Stop by Booth #113 after to try Alba for yourself and explore our diagnostic AI applications—looking forward to seeing you there!
-
Thrilled to be partnering with Gestalt to integrate Paige’s AI applications into their digital pathology platform, PathFlow!
We are happy to announce our latest AI partnership - with Paige and the integration of the Paige algorithms into our PathFlow platform. Giving customers, both existing and new, options to use the industry's leading algorithms based upon their preference is what our whole interoperability philosophy is based upon.